Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Apr 22;13(1):442-448.
doi: 10.1159/000506896. eCollection 2020 Jan-Apr.

Neutropenic Enterocolitis in the Treatment of Solid Tumors: A Case Report and Review of the Literature

Affiliations
Case Reports

Neutropenic Enterocolitis in the Treatment of Solid Tumors: A Case Report and Review of the Literature

Sara Cherri et al. Case Rep Oncol. .

Abstract

Neutropenic enterocolitis is a clinical condition characterized by inflammation of the colic mucosa, usually the caecum, associated with bowel wall thickening in patients with compromised immune system due to chemotherapy treatments. It can occur as well in other clinical conditions that lead to immunosuppression. Clinically, patients present with abdominal pain, fever, and neutropenia on blood tests. A number of major and minor criteria have been suggested for the clinical diagnosis of typhlitis. The most sensitive radiological investigation is represented by a computed tomography scan. There are no guidelines for treatment, but some factors may lead the clinician to medical treatments or prompt surgery as the best choice in that particular patient. The most implicated chemotherapeutic regimens are those based on taxanes. Here, we present a clinical case of a young patient with breast cancer and a review of the state of the art of knowledge regarding neutropenic enterocolitis in adult patients undergoing chemotherapy for the treatment of solid tumors.

Keywords: Colitis; Docetaxel; Neutropenic enterocolitis; Typhlitis.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
CT scan image.
Fig. 2
Fig. 2
Image of the resected colon.
Fig. 3
Fig. 3
Image of the pathological anatomy.

References

    1. Ramsingh J, Bolln C, Hodnett R, Al-Ani A. Neutropenic enterocolitis affecting the transverse colon: an unusual complication of chemotherapy. BMJ Case Rep. 2014 May 2;2014(pii):bcr2014204035. - PMC - PubMed
    1. Mehdi I, Al Bahrani B. Chemotherapy-induced neutropenic necrotizing enterocolitis: a review. J Pak Med Assoc. 2012 Jul;62((7)):718–23. - PubMed
    1. Qasim A, Nahas J. Neutropenic enterocolitis (typhlitis). StatPearls. Treasure Island (FL): StatPearls Publishing; 2019. - PubMed
    1. Bremer CT, Monahan BP. Necrotizing enterocolitis in neutropenia and chemotherapy: a clinical update and old lessons relearned. Curr Gastroenterol Rep. 2006 Aug;8((4)):333–41. - PubMed
    1. Oehadian A, Fadjari TH. Neutropenic enterocolitis in breast cancer patient after taxane-containing chemotherapy. Acta Med Indones. 2008 Jan;40((1)):29–33. - PubMed

Publication types